Cynata Therapeutics Ord Shs V.CYP

Primary Symbol: CYYNF

Healthcare Biotechnology

Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and regenerative medicine company. The Company is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells and a precursor cell, mesenchymoangioblast (MCA) to manufacture cell therapy products, including mesenchymal stem cells, on a commercial scale. Its lead product candidate, CYP-001, is under Phase I trial and developed for the treatment of steroid-resistant acute graft-versus-host disease (GvHD). Clinical trials of Cymerus products in osteoarthritis, which is under Phase III trial, and diabetic foot ulcers (DFU) are ongoing. In addition, the Company has demonstrated the utility of its Cymerus technology in preclinical models of various diseases, including critical limb ischaemia, idiopathic pulmonary fibrosis, asthma, heart attack, sepsis, acute respiratory distress syndrome and other.

OTCPK:CYYNF - Post by User

Cynata Therapeutics Ord Shs > Oh...the weekend !!

<< Previous

Bullboard Posts

Next >>

Comment by metalhead666on Sep 30, 2022 10:30am

138 Views

Post# 34997392

RE:Oh...the weekend !!

I don't think anyone manipulates....the short term issue is one of exposure. No one knows who Cypress is being listed on the venture. Once the FS is out that will change quickly. The company needs to get on a real exchange and I think they know this. With the FS in hand and a proper listing this stock is going to take off. I don't know of any company with the upside potential as great as it is with Cypress. Just need to get the story out there, deliver the FS, get uplisted and it will soar. I'm not the only one who can do the arithmetic on 50k tons of production fetching $70k per ton!

<< Previous

Bullboard Posts

Next >>

A junior copper-gold stock trading at a bargain of monumental proportions